Trisalus Life Sciences, Inc. · NASDAQ:TLSI

Trisalus Life Sciences — SPAC Merger (November 2022)

7 slides from Trisalus Life Sciences's SPAC merger presentation, Nov 14, 2022

1. Slide 1: Exhibit 99.2

   Exhibit 99.2

2. Slide 2: TriSalus Life Sciences to Become Publicly Traded Through Merger with MedTech Acquisition Corporation

   Al Salus TriSalus Life Sciences to Become Publicly Traded Through Merger with MedTech Acquisition Corporation v Accelerating Access to Resources to Drive Continued Commercialization of TriNav® Infusion System and Advance SD-101 Clinical Programs Transformational Upside Potential TriSalus’ two-pronge

3. Slide 3: TriSalus Life Sciences to Become Publicly Traded Through Merger with MedTech Acquisition Corporation

   TriSalus Life Sciences to Become Publicly Traded Through Merger with MedTech Acquisition CorporationAccelerating Access to Resources to Drive Continued Commercialization of TriNav® Infusion System and Advance SD-101 Clinical ProgramsTransformational Upside PotentialTriSalus’ two-pronged platform com

4. Slide 4: Slide 4

5. Slide 5: Forward-Looking Statements

   Forward-Looking Statements This communication contains certain “forward-looking statements” within the meaning of the United States federal securities laws regarding MedTech’'s or TriSalus’s expectations, hopes, beliefs, assumptions, intentions or strategies regarding the future including, without l

6. Slide 6: Forward-Looking Statements

   Forward-Looking Statements This communication contains certain “forward-looking statements” within the meaning of the United States federal securities laws regarding MedTech’s or TriSalus’s expectations, hopes, beliefs, assumptions, intentions or strategies regarding the future including, without li

7. Slide 7: Slide 7

TriSalus Life Sciences — SPAC Merger (November 2022) on 6ix